Burke Pharmaceutical Research

Hot Springs, Arizona 71913

0 studies enrolling now · 7 studies all time

What they study most

Actinic Keratoses, Actinic Keratosis, Moderate and Severe Plaque Psoriasis, Plaque-type Psoriasis

Studies at this site

• Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis — Completed
• A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis — Completed
• A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) — Completed
• A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies — Completed
• A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study — Completed
• A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) — Completed
• A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations — Completed